Evidence map›Paper›PMID 41355345›Full record

ArticleBrain and behavior2025

Migraine Disease Burden and Trends (1990-2021): A Multidimensional Comparative Analysis of China and Other G20 Countries.

Rong Yang, Wen Chen, Mou Sun, Hao Feng, Bing Chen, Xiaoquan Luo, Zhou Li, Fei Qiao, Hui Tang, Haibo Ren

Abstract readComparative Study
In one paragraph

Article in Brain and behavior, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Rong YangBeijing Anzhen Nanchong Hospital of Capital Medical University & Nanchong Central Hospital, Nanchong, Sichuan, China.
Wen ChenBeijing Anzhen Nanchong Hospital of Capital Medical University & Nanchong Central Hospital, Nanchong, Sichuan, China.
Mou SunBeijing Anzhen Nanchong Hospital of Capital Medical University & Nanchong Central Hospital, Nanchong, Sichuan, China.
Hao FengBeijing Anzhen Nanchong Hospital of Capital Medical University & Nanchong Central Hospital, Nanchong, Sichuan, China.
Bing ChenBeijing Anzhen Nanchong Hospital of Capital Medical University & Nanchong Central Hospital, Nanchong, Sichuan, China.
Xiaoquan LuoBeijing Anzhen Nanchong Hospital of Capital Medical University & Nanchong Central Hospital, Nanchong, Sichuan, China.
Zhou LiBeijing Anzhen Nanchong Hospital of Capital Medical University & Nanchong Central Hospital, Nanchong, Sichuan, China.
Fei QiaoBeijing Anzhen Nanchong Hospital of Capital Medical University & Nanchong Central Hospital, Nanchong, Sichuan, China.
Hui TangBeijing Anzhen Nanchong Hospital of Capital Medical University & Nanchong Central Hospital, Nanchong, Sichuan, China.
Haibo RenBeijing Anzhen Nanchong Hospital of Capital Medical University & Nanchong Central Hospital, Nanchong, Sichuan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMigraine is a prevalent neurological disorder causing significant suffering and imposing a substantial burden on healthcare systems. Utilizing data from the Global Burden of Disease Study (GBD) 2021, this study comprehensively analyzes the current status, historical trends (1990-2021), and future projections of migraine burden in China and other G20 countries. The aim is to provide scientific evidence to inform evidence-based health strategies.

methodsWe analyzed GBD 2021 data to calculate migraine incidence, prevalence, disability-adjusted life years (DALYs), and years lived with disability (YLDs) from 1990 to 2021. Statistical analyses characterized these metrics across age, sex, year, geographical region, and the sociodemographic index (SDI). Trends in China and other G20 countries were tracked. Future trends (2022-2050) were projected using exponential smoothing (ES) and autoregressive integrated moving average (ARIMA) models. The Bayesian age-period-cohort (BAPC) model quantified the effects of age, period, and cohort factors on incidence, elucidating long-term burden drivers.

resultMigraine burden exhibited significant age dependency, with a bimodal age pattern. A pronounced gender disparity was evident, with females bearing a consistently higher burden across all metrics (e.g., prevalence approximately twice that of males). From 1990 to 2021, the migraine burden demonstrated a dual-track trajectory: An overall increase in total burden accompanied by a widening gender gap. Predictive models project a concerning future: Without effective interventions, the migraine burden during 2030-2050 will feature further escalation of the gender imbalance. The BAPC model indicates a projected century-long intensification of the migraine burden.

conclusionsThe migraine disease burden possesses distinct age and sex dimensions, revealing significant disparities across SDI regions, countries, age groups, and genders. The escalating burden necessitates targeted interventions and public health initiatives, particularly in regions and populations disproportionately affected.

Indexed as

Cost of IllnessMigraine DisordersAdolescentAdultAgedChinaDisability-Adjusted Life YearsFemaleGlobal Burden of DiseaseHumansIncidenceMaleMiddle AgedPrevalenceQuality-Adjusted Life YearsYoung Adultautoregressive integrated moving average (ARIMA)Bayesian age‐period‐cohort (BAPC)disability‐adjusted life years (DALYs)disease burdenexponential smoothing (ES)GBDmigrainesociodemographic index (SDI)years lived with disability (YLDs)

Identifiers

PMID41355345
PMCPMC12683068

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.